Skip to content

Effect of Neuromuscular Reversal With Sugammadex on Postoperative Recovery Profile

Effect of Neuromuscular Blockade Reversal With Sugammadex on Oxygenation, Pain and Arousal States in the Post Anesthesia Care Unit

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02243943
Acronym
Neuropa
Enrollment
100
Registered
2014-09-18
Start date
2014-09-30
Completion date
2016-04-30
Last updated
2017-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Respiratory Condition

Keywords

Neuromuscular block, neuromuscular reversal, postoperative conditions, respiratory failure

Brief summary

Suboptimal reversal of neuromuscular blockage after surgery is possibly related to unfavorable postoperative respiratory conditions and elevated pain levels. Rapid and complete reversal of neuromuscular block was not possible untill sugammadex was discovered. The investigators hyposthesise that reversal with sugammadex leads to favorable postoperative respiratory conditions and less pain compared to reversal with neostigmine.

Interventions

DRUGSugammadex
DRUGNeostigmine

Sponsors

Leiden University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 years * \- BMI \< 35 * -ASA class I- III * -Patients scheduled for surgery requiring general anesthesia with the use of NMBA's * Patients with ability to give oral and written informed consent

Exclusion criteria

* Failure to meet the inclusion criteria * -Known or suspected neuromuscular disorders impairing neuromuscular function * -Allergies to muscle relaxants, anesthetics or narcotics * A (family) history of malignant hyperthermia * -Women who are or may be pregnant or are currently breast feeding * -Contraindications for the use of neostigmine * Intestinal obstruction, * COPD GOLD 4 * -Abnormal heart rhythm (eg. bradycardia: \< 40/min); * -Surgery requiring neuraxial anesthesia / analgesia * -Preoperative cognitive dysfunction or mental disabilities * -Preexistent significant pulmonary disease with preoperative SpO2 \< 90% * -Preoperative ICU treatment / intubation (ICU patient); * -Need for postoperative ICU treatment or ventilation;

Design outcomes

Primary

MeasureTime frameDescription
Mean Lowest Saturation45 minutes post surgeryMean saturation is the mean value of the beat-to-beat Hb-oxygen saturation measured by finger pulse oximeter as measured in the first 45 min in the recovery room following surgery

Secondary

MeasureTime frameDescription
Pain45 minutes post surgeryusing the 1-10 numeric rating scale
Sedation45 minutes post surgeryusing the Leiden observer alertness score (1 alert - 5 sedated)

Countries

Netherlands

Participant flow

Participants by arm

ArmCount
Sugammadex
Subjects in this arm will be reversed with sugammadex 2-4 mg/kg Sugammadex
50
Neostigmine
subjects in this arm will be reversed with neostigmine 1.0-2.5 mg and atropine 0.5-1.0mg Neostigmine
50
Total100

Baseline characteristics

CharacteristicSugammadexNeostigmineTotal
Age, Continuous55 years of age55 years of age55 years of age
Gender
Female
27 Participants24 Participants51 Participants
Gender
Male
23 Participants26 Participants49 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 500 / 50
serious
Total, serious adverse events
0 / 500 / 50

Outcome results

Primary

Mean Lowest Saturation

Mean saturation is the mean value of the beat-to-beat Hb-oxygen saturation measured by finger pulse oximeter as measured in the first 45 min in the recovery room following surgery

Time frame: 45 minutes post surgery

ArmMeasureValue (MEAN)
SugammadexMean Lowest Saturation96.8 percentage of oxygen saturation
NeostigmineMean Lowest Saturation93.3 percentage of oxygen saturation
Secondary

Pain

using the 1-10 numeric rating scale

Time frame: 45 minutes post surgery

ArmMeasureValue (MEAN)
SugammadexPain3.0 Numeric rating scale. 1(low)-10(maximum)
NeostigminePain3.2 Numeric rating scale. 1(low)-10(maximum)
Secondary

Sedation

using the Leiden observer alertness score (1 alert - 5 sedated)

Time frame: 45 minutes post surgery

ArmMeasureValue (MEAN)
SugammadexSedation1.4 sedation scale (1 alert - 5 sedated)
NeostigmineSedation1.4 sedation scale (1 alert - 5 sedated)

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026